CN113974004A - Feed additive suitable for weaned piglets - Google Patents
Feed additive suitable for weaned piglets Download PDFInfo
- Publication number
- CN113974004A CN113974004A CN202111155343.1A CN202111155343A CN113974004A CN 113974004 A CN113974004 A CN 113974004A CN 202111155343 A CN202111155343 A CN 202111155343A CN 113974004 A CN113974004 A CN 113974004A
- Authority
- CN
- China
- Prior art keywords
- parts
- feed additive
- compound
- vitamin
- following raw
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003674 animal food additive Substances 0.000 title claims abstract description 29
- 239000003814 drug Substances 0.000 claims abstract description 21
- 150000001875 compounds Chemical class 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 229940088594 vitamin Drugs 0.000 claims abstract description 15
- 229930003231 vitamin Natural products 0.000 claims abstract description 15
- 235000013343 vitamin Nutrition 0.000 claims abstract description 15
- 239000011782 vitamin Substances 0.000 claims abstract description 15
- 244000005700 microbiome Species 0.000 claims abstract description 13
- -1 compound vitamin Chemical class 0.000 claims abstract description 12
- 241000282887 Suidae Species 0.000 claims abstract description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 9
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229940079593 drug Drugs 0.000 claims abstract description 9
- 239000008103 glucose Substances 0.000 claims abstract description 9
- 229910052901 montmorillonite Inorganic materials 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims description 12
- 102000007544 Whey Proteins Human genes 0.000 claims description 9
- 108010046377 Whey Proteins Proteins 0.000 claims description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 8
- 239000005862 Whey Substances 0.000 claims description 8
- 244000063299 Bacillus subtilis Species 0.000 claims description 6
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 6
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 6
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 6
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 6
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 6
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 6
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 6
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 6
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 6
- 240000000171 Crataegus monogyna Species 0.000 claims description 6
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 6
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 6
- 235000019733 Fish meal Nutrition 0.000 claims description 6
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 6
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 6
- 244000197580 Poria cocos Species 0.000 claims description 6
- 235000008599 Poria cocos Nutrition 0.000 claims description 6
- 235000006533 astragalus Nutrition 0.000 claims description 6
- 239000004467 fishmeal Substances 0.000 claims description 6
- 241000132012 Atractylodes Species 0.000 claims description 5
- 241000194108 Bacillus licheniformis Species 0.000 claims description 5
- 241000007126 Codonopsis pilosula Species 0.000 claims description 5
- 240000006079 Schisandra chinensis Species 0.000 claims description 5
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 5
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 5
- 235000011477 liquorice Nutrition 0.000 claims description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- 229930003316 Vitamin D Natural products 0.000 claims description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 235000019155 vitamin A Nutrition 0.000 claims description 4
- 239000011719 vitamin A Substances 0.000 claims description 4
- 235000019166 vitamin D Nutrition 0.000 claims description 4
- 239000011710 vitamin D Substances 0.000 claims description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- 229940046008 vitamin d Drugs 0.000 claims description 4
- 241000045403 Astragalus propinquus Species 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 230000036039 immunity Effects 0.000 abstract description 6
- 238000011161 development Methods 0.000 abstract description 5
- 230000000968 intestinal effect Effects 0.000 abstract description 5
- 210000004347 intestinal mucosa Anatomy 0.000 abstract description 2
- 239000005667 attractant Substances 0.000 abstract 1
- 230000031902 chemoattractant activity Effects 0.000 abstract 1
- 230000003871 intestinal function Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 13
- 206010012735 Diarrhoea Diseases 0.000 description 9
- 230000006870 function Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 108060003951 Immunoglobulin Proteins 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 102000018358 immunoglobulin Human genes 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 241001061264 Astragalus Species 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 210000004233 talus Anatomy 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 235000019621 digestibility Nutrition 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 235000021050 feed intake Nutrition 0.000 description 3
- 229940088592 immunologic factor Drugs 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 208000035240 Disease Resistance Diseases 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 108010023244 Lactoperoxidase Proteins 0.000 description 1
- 102000045576 Lactoperoxidases Human genes 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 231100000678 Mycotoxin Toxicity 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000433 anti-nutritional effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 229940057428 lactoperoxidase Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000002636 mycotoxin Substances 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
- A23K10/22—Animal feeding-stuffs from material of animal origin from fish
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
- A23K10/26—Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin
- A23K10/28—Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin from waste dairy products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
- A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/28—Silicates, e.g. perlites, zeolites or bentonites
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Birds (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Feed For Specific Animals (AREA)
Abstract
The invention discloses a feed additive suitable for weaned pigs, which belongs to the field of feed additives and comprises the following raw material medicines in parts by weight: 8-16 parts of glucose, 14-23 parts of montmorillonite, 30-45 parts of carrier, 10-20 parts of compound microorganism, 2-3 parts of compound vitamin and 10-20 parts of compound traditional Chinese medicine. The invention can not only adjust the intestinal function, promote the development of intestinal mucosa, maintain the flora balance of the intestinal system, improve the immunity of the organism, but also enhance the feed attractant and improve the growth performance of piglets.
Description
Technical Field
The invention relates to the field of feed additives, in particular to a feed additive suitable for weaned piglets.
Background
The weaning of piglets is an important link in the pig raising production. During weaning, piglets are stressed due to changes in environment and nutrition, and the intestinal microecological balance can be changed, so that pathogenic bacteria can be proliferated in the intestinal tract, and the health and growth of the piglets are affected.
Weaned piglets have the characteristics of fast growth and development, lack of innate immunity, immature digestive function and the like, and the weaned piglets are low in feed intake, low in digestibility, slow in growth and even negatively increased, easy to diarrhea and high in mortality rate due to weaning stress. The harm caused by diarrhea is the first place, so that the healthy breeding of the weaned piglets is always a difficult problem in the pig industry, whether the weaned piglets can safely pass the weaning period and grow well can have great influence on survival and later growth and development until the piglets come into the market, and the method is the key for obtaining benefit in pig production.
Disclosure of Invention
The invention aims to provide a feed additive suitable for weaned pigs, which solves the problems in the prior art, promotes the growth and development of the weaned pigs, and has better prevention and treatment effects on diarrhea of the piglets.
In order to achieve the purpose, the invention provides the following scheme:
the invention provides a feed additive suitable for weaned piglets, which is prepared from the following raw material medicines in parts by weight: 8-16 parts of glucose, 14-23 parts of montmorillonite, 30-45 parts of carrier, 10-20 parts of compound microorganism, 2-3 parts of compound vitamin and 10-20 parts of compound traditional Chinese medicine.
Further, the feed additive is composed of the following raw material medicines in parts by weight: 12 parts of glucose, 18 parts of montmorillonite, 38 parts of carrier, 15 parts of compound microorganism, 2 parts of compound vitamin and 15 parts of compound traditional Chinese medicine.
Further, the carrier is composed of the following raw materials in parts by weight: 50-60 parts of corncob powder, 20-30 parts of whey powder and 15-25 parts of fish meal.
Further, the complex microorganism is composed of the groundConsists of bacillus licheniformis and bacillus subtilis, and the number of the live bacteria in the feed additive is more than or equal to 108cfu/g。
Further, the compound vitamin is prepared from the following raw materials in parts by weight: 0.5-1.0 part of vitamin A, 30.1-0.5 part of vitamin D and 1.0-2.0 parts of vitamin E.
Further, the compound traditional Chinese medicine is prepared from the following raw materials in parts by weight: 10-16 parts of astragalus membranaceus, 18-24 parts of acanthopanax, 4-9 parts of codonopsis pilosula, 10-16 parts of schisandra chinensis, 15-20 parts of hawthorn, 8-14 parts of bighead atractylodes rhizome, 9-14 parts of poria cocos and 7-13 parts of liquorice.
In the invention, the main functions of the components are as follows:
glucose: the flavor of the feed can be improved, the unpleasant taste in the feed can be covered, and the appetite can be stimulated, so that the feed intake of piglets is increased; the health-care food can improve immunity, can be quickly absorbed from small intestines, increase physical ability, supplement nutrition and store in liver, protect liver cells from being damaged by harmful factors, and promote the activity of reticuloendothelial system cells and liver cells, thereby enhancing the resistance to infectious diseases and viral diseases, greatly reducing the morbidity of piglets and obviously reducing death caused by unknown reasons.
Montmorillonite: the feed additive can effectively relieve the damage of piglet weaning stress to the gastrointestinal tract mucosa morphological structure, simultaneously inhibit the growth of harmful bacteria in piglet intestinal tracts to promote the propagation of advocated beneficial bacteria, improve the digestion and absorption capacity of weaned piglets, and further reduce the diarrhea caused by piglet weaning.
Corncob meal: the xylo-oligosaccharide can promote the proliferation of advocated beneficial bacteria and improve the intestinal flora structure; reducing the pathogenic capability of pathogenic bacteria; improving the immune function of the organism; protecting the livers of the piglets; promoting the absorption and utilization of vitamins.
Whey powder: can provide a large amount of lactose, can produce a large amount of lactic acid by fermentation in the digestive tract of piglets, reduce the pH value, help digestion and inhibit the growth of pathogenic bacteria; the high-quality whey protein contained in the whey powder has the advantages of high digestibility, good amino acid form and no anti-nutritional factors in piglets, also contains albumin and globulin (serum protein), has positive influence on intestinal tracts, particularly has immunoglobulin, has a protection effect on the intestinal tracts, and can resist escherichia coli; the whey powder also contains lactoperoxidase and lactoferrin, and has antibacterial and bacteriostatic effects.
Fish meal: as animal protein, the amino acid proportion is closest to that required by animals, and the growth of piglets requires the protein and requires the protein to have a larger amino acid proportion.
Bacillus licheniformis and bacillus subtilis: can regulate intestinal flora of piglets, increase beneficial bacteria amount, and generate enzymes such as alpha amylase, protease, lipase, etc., and various nutrients such as vitamin B1, B2, B6, etc., thereby improving immunity of piglets.
Vitamin complex: the vitamins can obviously improve the growth performance of early weaned piglets, can enhance the immunity of organism cells and reduce inflammatory reaction; can intensify the antioxidation of the body of the piglet.
Compounding the traditional Chinese medicines: astragalus polysaccharides are the main components of astragalus root. Radix astragali has effects of invigorating qi, consolidating exterior, arresting sweating, promoting granulation, inducing diuresis, and relieving swelling. Modern medical research shows that astragalus has the functions of enhancing the immunity of organisms, protecting the liver, promoting urination, resisting aging, resisting stress, reducing blood pressure and resisting a wide range of bacteria. Can eliminate albuminuria caused by experimental nephritis, enhance myocardial contraction force, and regulate blood sugar content. Radix astragali has antibacterial effect on in vitro Shigella dysenteriae, Bacillus anthracis, alpha-Streptococcus sanguis, Bacillus diphtheriae, Bacillus pseudodiphtheriae, Diplococcus pneumoniae, Staphylococcus aureus, Staphylococcus citreus, Staphylococcus albus, and Bacillus subtilis.
Acanthopanax root: has ginseng-like adaptogen effect, and can enhance nonspecific defense ability; has effects in lowering blood sugar, tranquilizing mind, and tranquilizing mind; has antioxidant and antiaging effects; improving the functions of each organ system.
Codonopsis pilosula: has effects of exciting nervous system, enhancing resistance of weaned pig, regulating gastrointestinal motility, and resisting ulcer.
Schisandra chinensis: invigorating qi, invigorating yang, consolidating superficial resistance, arresting sweating, inducing diuresis, relieving swelling, expelling toxin, and expelling pus.
Hawthorn fruit: has effects of reducing blood lipid and blood pressure, tonifying heart, and resisting arrhythmia, and is also effective in invigorating spleen, stimulating appetite, promoting digestion, removing food stagnation, promoting blood circulation, and eliminating phlegm. The vitexin in hawthorn is a flavonoid compound with strong anticancer effect.
White atractylodes rhizome: has effects of invigorating spleen, invigorating qi, eliminating dampness, promoting diuresis, arresting sweating, and preventing miscarriage.
Tuckahoe, poria cocos: has the functions of promoting diuresis, eliminating dampness, benefiting spleen and calming heart, and mainly treats the following diseases: fatigue due to qi deficiency, edema, phlegm-fluid retention, emesis, diarrhea, spermatorrhea, pyretic stranguria, palpitation, and amnesia.
Licorice root: has the effects of invigorating spleen and replenishing qi, moistening lung for arresting cough, purging fire for removing toxic substance, relieving spasm and pain, and harmonizing various aspects of the medicines. Modern medical research shows that the liquorice has the effects of resisting virus, resisting inflammation and protecting liver, and can be used for treating spleen deficiency, cough and asthma, sore throat, carbuncle, sore and pyogenic infections and the like.
The invention discloses the following technical effects:
aiming at the physiological characteristics and nutritional requirements of the piglets after early weaning, the invention obtains effective additive composition through mass screening, and improves the palatability and digestibility of the feed; meanwhile, whey powder, fish meal and the like are applied according to the digestive physiological characteristics of the weaned piglets, so that the palatability of the feed is improved, the feed intake of the weaned piglets is increased, the deficiency of stomach acid and digestive enzyme secretion of the piglets is supplemented, the digestive utilization rate of the feed is improved, and the growth of the piglets can be promoted.
The feed can maintain intestinal microecological balance, improve nutrition supply and intestinal mucosa repair, strengthen digestion and absorption functions, further reduce the diarrhea rate of weaned pigs, relieve diarrhea symptoms, promote the growth and development of early weaned pigs, improve the disease resistance, enhance the immunity of the piglets, promote the growth of the piglets, adsorb mycotoxin in the feed, effectively prevent the diarrhea of the weaned pigs and improve the economic benefit.
Detailed Description
Reference will now be made in detail to various exemplary embodiments of the invention, the detailed description should not be construed as limiting the invention but as a more detailed description of certain aspects, features and embodiments of the invention.
It is to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. Further, for numerical ranges in this disclosure, it is understood that each intervening value, between the upper and lower limit of that range, is also specifically disclosed. Every smaller range between any stated value or intervening value in a stated range and any other stated or intervening value in a stated range is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although only preferred methods and materials are described herein, any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention. All documents mentioned in this specification are incorporated by reference herein for the purpose of disclosing and describing the methods and/or materials associated with the documents. In case of conflict with any incorporated document, the present specification will control.
It will be apparent to those skilled in the art that various modifications and variations can be made in the specific embodiments of the present disclosure without departing from the scope or spirit of the disclosure. Other embodiments will be apparent to those skilled in the art from consideration of the specification. The specification and examples are exemplary only.
As used herein, the terms "comprising," "including," "having," "containing," and the like are open-ended terms that mean including, but not limited to.
The "parts" in the present invention are all parts by mass unless otherwise specified.
Example 1
A feed additive suitable for weaned piglets consists of the following raw material medicines in parts by weight: 8 parts of glucose, 14 parts of montmorillonite, 30 parts of carrier, 10 parts of compound microorganism, 2 parts of compound vitamin and 10 parts of compound traditional Chinese medicine.
Wherein, the carrier is composed of 50 parts of corncob powder, 20 parts of whey powder and 15 parts of fish meal; the composite microorganism has viable count of 108cfu/g of bacillus licheniformis and bacillus subtilis; the compound vitamin comprises 0.5 part of vitamin A, 30.1 parts of vitamin D and 1.0 part of vitamin E; the compound traditional Chinese medicine consists of 10 parts of astragalus, 18 parts of acanthopanax, 4 parts of codonopsis pilosula, 10 parts of schisandra chinensis, 15 parts of hawthorn, 8 parts of bighead atractylodes rhizome, 9 parts of poria cocos and 7 parts of liquorice.
Example 2
The difference from the embodiment 1 is that the feed additive is composed of the following raw material medicines in parts by weight: 12 parts of glucose, 18 parts of montmorillonite, 38 parts of carrier, 15 parts of compound microorganism, 2 parts of compound vitamin and 15 parts of compound traditional Chinese medicine.
Example 3
The difference from the embodiment 1 is that the feed additive is composed of the following raw material medicines in parts by weight: 16 parts of glucose, 23 parts of montmorillonite, 45 parts of carrier, 20 parts of compound microorganism, 3 parts of compound vitamin and 20 parts of compound traditional Chinese medicine.
Example 4
The difference from the example 1 is that the carrier is composed of the following raw materials in parts by weight: 60 parts of corncob powder, 30 parts of whey powder and 25 parts of fish meal.
Example 5
The difference from the example 1 is that the composite microorganism consists of bacillus licheniformis and bacillus subtilis, and the number of the live bacteria in the feed additive is 2 multiplied by 108cfu/g。
Example 6
The difference from the embodiment 1 is that the compound vitamin comprises 0.5 part of vitamin A, 30.5 parts of vitamin D and 2.0 parts of vitamin E.
Example 7
The difference from the embodiment 1 is that the compound traditional Chinese medicine is prepared from the following raw materials in parts by weight: 16 parts of astragalus, 24 parts of acanthopanax, 9 parts of codonopsis pilosula, 16 parts of schisandra, 20 parts of hawthorn, 14 parts of bighead atractylodes rhizome, 14 parts of poria cocos and 13 parts of liquorice.
Comparative example 1
The difference from example 1 is that the feed additive does not contain complex microorganisms.
Application example
50 weaned piglets are randomly divided into 5 groups, each group comprises 10 weaned piglets, and the feed additive of the above embodiment is added into piglet feed at an amount of 0.15% to feed the weaned piglets, wherein the blank control group is not added with the feed additive. Growth performance of weaned piglets is shown in table 1:
TABLE 1 growth Performance of weaned piglets
The data show that the feed additive has obvious effects on piglet daily gain, feed utilization rate improvement and diarrhea rate reduction, and is obviously superior to a comparative example and a blank control group.
The immunoglobulin content of weaned pigs is shown in table 2:
TABLE 2 content of immunoglobulin (μ g/ml) of weaned piglets
| IgA | IgM | IgG | |
| Blank control | 35.29 | 14.02 | 144.2 |
| Comparative example | 40.12 | 15.24 | 195.1 |
| Example 1 | 42.89 | 15.91 | 196.0 |
| Example 2 | 43.75 | 16.05 | 197.6 |
| Example 3 | 43.07 | 15.77 | 195.8 |
The immune factor content in weaned piglets is shown in table 3:
TABLE 3 immune factor content (pg/ml) in weaned piglets
| IL-2 | IL-4 | TNF-α | |
| Blank control | 135.2 | 85.01 | 42.1 |
| Comparative example | 176.1 | 175.2 | 60.8 |
| Example 1 | 190.0 | 183.6 | 66.1 |
| Example 2 | 194.2 | 187.6 | 64.9 |
| Example 3 | 188.9 | 181.9 | 64.8 |
The data show that the feed additive has the function of increasing the contents of main immune globulin and part of immune cytokines in the blood of the weaned pigs, thereby enhancing the disease resistance of the weaned pigs. And the immunoglobulin and immune factor content of the weaned piglets is obviously higher than that of the blank pair fraud and the comparative example.
The above-described embodiments are merely illustrative of the preferred embodiments of the present invention, and do not limit the scope of the present invention, and various modifications and improvements of the technical solutions of the present invention can be made by those skilled in the art without departing from the spirit of the present invention, and the technical solutions of the present invention are within the scope of the present invention defined by the claims.
Claims (6)
1. A feed additive suitable for weaned piglets is characterized in that: the feed additive is composed of the following raw material medicines in parts by weight: 8-16 parts of glucose, 14-23 parts of montmorillonite, 30-45 parts of carrier, 10-20 parts of compound microorganism, 2-3 parts of compound vitamin and 10-20 parts of compound traditional Chinese medicine.
2. The feed additive suitable for weaned piglets according to claim 1, characterized in that: the feed additive is composed of the following raw material medicines in parts by weight: 12 parts of glucose, 18 parts of montmorillonite, 38 parts of carrier, 15 parts of compound microorganism, 2 parts of compound vitamin and 15 parts of compound traditional Chinese medicine.
3. The feed additive suitable for weaned piglets according to claim 1, characterized in that: the carrier is composed of the following raw materials in parts by weight: 50-60 parts of corncob powder, 20-30 parts of whey powder and 15-25 parts of fish meal.
4. The feed additive for weaned piglets according to claim 1, wherein said complex microorganism comprises Bacillus licheniformis and Bacillus subtilis, and the number of viable bacteria in said feed additive is not less than 108cfu/g。
5. The feed additive for weaned pigs according to claim 1, wherein the vitamin complex comprises the following raw materials in parts by weight: 0.5-1.0 part of vitamin A, 30.1-0.5 part of vitamin D and 1.0-2.0 parts of vitamin E.
6. The feed additive suitable for weaned piglets according to claim 1, characterized in that: the compound traditional Chinese medicine is prepared from the following raw materials in parts by weight: 10-16 parts of astragalus membranaceus, 18-24 parts of acanthopanax, 4-9 parts of codonopsis pilosula, 10-16 parts of schisandra chinensis, 15-20 parts of hawthorn, 8-14 parts of bighead atractylodes rhizome, 9-14 parts of poria cocos and 7-13 parts of liquorice.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111155343.1A CN113974004A (en) | 2021-09-29 | 2021-09-29 | Feed additive suitable for weaned piglets |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111155343.1A CN113974004A (en) | 2021-09-29 | 2021-09-29 | Feed additive suitable for weaned piglets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113974004A true CN113974004A (en) | 2022-01-28 |
Family
ID=79737311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111155343.1A Pending CN113974004A (en) | 2021-09-29 | 2021-09-29 | Feed additive suitable for weaned piglets |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113974004A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113974010A (en) * | 2021-09-29 | 2022-01-28 | 河南普旺生物工程有限公司 | Feed additive for weaning of bred animals and use method |
| CN115024414A (en) * | 2022-06-15 | 2022-09-09 | 北京都润科技有限公司 | Weaned piglet feed additive and preparation method and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109247450A (en) * | 2017-07-14 | 2019-01-22 | 程艳青 | A kind of preparation method of early-weaned piglets feed |
| CN110604226A (en) * | 2018-06-15 | 2019-12-24 | 江苏奥迈生物科技有限公司 | Diarrhea-preventing growth-promoting composite feed additive for weaned piglets and preparation method thereof |
| CN112006181A (en) * | 2020-08-21 | 2020-12-01 | 安徽绿保源养殖有限公司 | Weaned piglet feed |
-
2021
- 2021-09-29 CN CN202111155343.1A patent/CN113974004A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109247450A (en) * | 2017-07-14 | 2019-01-22 | 程艳青 | A kind of preparation method of early-weaned piglets feed |
| CN110604226A (en) * | 2018-06-15 | 2019-12-24 | 江苏奥迈生物科技有限公司 | Diarrhea-preventing growth-promoting composite feed additive for weaned piglets and preparation method thereof |
| CN112006181A (en) * | 2020-08-21 | 2020-12-01 | 安徽绿保源养殖有限公司 | Weaned piglet feed |
Non-Patent Citations (1)
| Title |
|---|
| 梁春凤等: "零排放生态养猪技术", vol. 1, 湘潭大学出版社, pages: 78 - 79 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113974010A (en) * | 2021-09-29 | 2022-01-28 | 河南普旺生物工程有限公司 | Feed additive for weaning of bred animals and use method |
| CN115024414A (en) * | 2022-06-15 | 2022-09-09 | 北京都润科技有限公司 | Weaned piglet feed additive and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111869788A (en) | Biological feed for improving laying performance and egg quality of laying hens in later period of egg laying and preparation method thereof | |
| CN110338141B (en) | Application of whole-course antibiotic-free breeding technical scheme in laying hen breeding | |
| CN104186948A (en) | Total-effect health concentrated feed for pigs | |
| CN113974004A (en) | Feed additive suitable for weaned piglets | |
| CN105076898A (en) | Eco-nutritional compound feed for laying hens at egg-laying peak and preparation method of eco-nutritional compound feed | |
| CN107006705A (en) | Groove feed for pigling and preparation method thereof | |
| CN111820332A (en) | Chinese herbal medicine laying hen feed and preparation method thereof | |
| CN105767587A (en) | Traditional Chinese medicine microecological preparation for improving laying hen performance and preparation method of traditional Chinese medicine microecological preparation for improving laying hen performance | |
| CN110946907A (en) | Traditional Chinese medicine composition for young poultry, liquid fermented traditional Chinese medicine preparation and preparation method thereof | |
| CN111227126A (en) | Anti-diarrhea growth-promoting piglet feed additive and preparation method thereof | |
| CN105595005A (en) | Piglet creep feed capable of improving intestinal health and preparation method of piglet creep feed | |
| CN112568324A (en) | Composite probiotic fermented traditional Chinese medicine feed additive and preparation method and application thereof | |
| CN111280327A (en) | Compound feed for preventing diarrhea of weaned piglets and preparation method thereof | |
| CN114568602B (en) | Traditional Chinese medicine compound for improving growth performance and organism immunity of broiler chickens and preparation method and application thereof | |
| CN104543410B (en) | Disease-resistant pig feed additive of a kind of health care and preparation method thereof | |
| CN112244174A (en) | Laying hen compound feed for improving laying rate and hatchability and preparation method thereof | |
| CN105410448A (en) | Antibacterial peptide active chicken feed additive and preparation method thereof | |
| CN105285353A (en) | Rabbit rapid fattening feed and breeding method thereof | |
| Prudyus | Morphological characteristics of the duodenum of piglets fed with various feed additives | |
| CN112514995A (en) | Suckling pig immune milk powder rich in probiotics and prebiotics and preparation method thereof | |
| CN107927410A (en) | Piglet religion groove feed and preparation method thereof | |
| CN106721068A (en) | Composition and feed for adjusting animal intestinal tract microbial environment | |
| Litonina et al. | Application of enzyme probiotic drug developed based on microorganisms of the rumen of reindeer (Rangifer tarandus) in feeding cows | |
| CN109221697A (en) | Weaned piglets probiotic feed and preparation method thereof | |
| CN109497308A (en) | Piglet anti diar rhea additive for microbe feedstuff and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220128 |